NEW YORK (GenomeWeb News) – Quebec's government will provide C$10 million (US$9.9 million) over four years to launch a new personalized cancer medicine collaboration between private and public partners that will aim to integrate biomarkers into cancer care and reduce treatment costs.

The new Personalized Medicine Partnership for Cancer also will raise C$11.1 million from private-sector partners, and it will be led by the Montreal-based protein biomarker developer Caprion Proteome, according to the partners in the effort.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.